E-ISSN 2587-0831
1 Department of Cancer Genetics, Oncology Institute, İstanbul University, İstanbul, Turkey  
2 Department of Radiation Oncology, Oncology Institute, İstanbul University, İstanbul, Turkey  
3 Department of Medical Oncology, Oncology Institute, İstanbul University, İstanbul, Turkey  
Eur J Breast Health ; : -

Abstract

Objective: The current rearrangement ratio of BRCA1 and BRCA2 genes is not known in the Turkish population. Rearrangements are not routinely investigated in many Turkish laboratories. This creates problems and contradictions between clinics. Therefore, the aim of this study was to evaluate the distribution and frequency of rearrangements in BRCA1 and BRCA2 genes in high-risk families and also to clarify the limits of BRCA1 and BRCA2 testing in Turkey.

 

Materials and Methods: The study included 1809 patients at high risk of breast cancer or ovarian cancer. All patients were investigated for both small indels and rearrangements of BRCA genes using DNA sequencing and multiplex ligation-dependent probe amplification (MLPA) analysis.

 

Results: The overall frequency of rearrangements was 2% (25/1262). The frequency of rearrangements was 1.7% (18/1086) and 4% (9/206) in patients with breast cancer and ovarian cancer, respectively. The frequency of rearrangements was 3.7% (8/215) in patients with triple-negative breast cancer. The rearrangement rate was 7.7% (2/26) in patients with both breast and ovarian cancer.

 

Conclusions: Rearrangements were found with high rates and were strongly associated with bilateral and triple-negative status of patients with breast cancer, which are signs of high risk for breast and ovarian cancer. Analysis of rearrangements should definitely be included in routine clinical practice in Turkey for high-risk families and also for improved cancer risk prediction for families.

Key Words
Authors
All
Congresses
Author’s Corner
Survey
AVES | Copyright © 2018 Turkish Federation of Breast Diseases Associations | Latest Update: 29.03.2018